Indigenous vaccine against diarrhoea virus ‘safe’ A Phase III randomised, double-blind, placebo-controlled trial of 116E rotavirus vaccine undertaken in infants at 3 centres in India. Findings : safe for usage had modest efficacy of 56.4% against severe rotavirus gastroenteritis during the first year of life India witnesses 25% rotavirus deaths world … [Read more...] about Safe Vaccine Against Rotavirus Developed